Iambic Therapeutics, Inc.

Iambic Therapeutics, Inc. financial statements

Iambic Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 9.43MEODHD
Net income−USD 77.3MEODHD
Cash and equivalentsUSD 180.54MEODHD

Iambic Therapeutics, Inc. financials on 6ix · Iambic Therapeutics, Inc. on 6ix